BGM
PRQR icon

Burkehill Global Management’s ProQR Therapeutics PRQR Stock Holding History

Burkehill Global Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
+176,243
New +$290K 0.01% 172

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Burkehill Global Management's PRQR Position: Q2 2026 in Review

Burkehill Global Management opened a new position in ProQR Therapeutics (PRQR) in Q2 2026: 176,243 shares worth $328K. The stake represents 0.01% of the portfolio and ranks #172 among its holdings.

70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Burkehill Global Management held 176,243 shares of ProQR Therapeutics worth $328K as of Q2 2026.
  • ProQR Therapeutics was a new Burkehill Global Management position in Q2 2026.
  • ProQR Therapeutics made up 0.01% of Burkehill Global Management's portfolio in Q2 2026, its #172 holding.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.